Optimizing Access to Monoclonal Antibodies for COVID-19: US Perspective

Optimizing Access to Monoclonal Antibodies for COVID-19 Infection: The Global PerspectiveПодробнее

Increasing Use of Monoclonal Antibodies Treatment of COVID 19 (Feb. 11, 2021)Подробнее

COVID-19 Update: Monoclonal Antibody TreatmentПодробнее

Dr. Mary Dittrich: Administering Monoclonal Antibodies to High-Risk COVID-19 PatientsПодробнее

Equitable Access to Monoclonal Antibody Treatmentfor COVID-19Подробнее

COVID-19 Virtual Briefing Series Session 8: Monoclonal Antibody Therapy for COVID-19 Latino PatientsПодробнее

Monoclonal Antibody Therapy: COVID-19 TreatmentПодробнее

Live Q&A: Monoclonal Antibodies Treatment for COVID-19Подробнее

Monoclonal antibodies helping COVID-19 patientsПодробнее

Practices for Improving the Use of COVID-19 Monoclonal AntibodiesПодробнее

Monoclonal antibodies and can they treat coronavirusПодробнее

Engineering Optimized Anti SARS CoV 2 Antibody TherapeuticsПодробнее

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 TreatmentПодробнее

IAVI’s Global Call to Access for Monoclonal Antibodies for COVID-19 and Other DiseasesПодробнее

Monoclonal Antibodies for COVID-19: Who, When, and How?Подробнее

Dr. Jennifer Tuteur: The Importance of Equitable Access to Monoclonal Antibodies forCOVID-19Подробнее

Monoclonal Antibodies (mAbs) for Treatment and Prevention of COVID-19Подробнее

NH DHHS: Long term care facilities will have access to monoclonal antibody treatmentПодробнее

Monoclonal Antibodies for COVID-19 in Africa: Promise and PitfallsПодробнее